2023-2024 Regular Session • Massachusetts Legislature
S689: Relative to patient access to biomarker testing to provide appropriate therapy
Legislative Summary
For legislation relative to patient access to biomarker testing to provide appropriate therapy. Financial Services.
Bill History
2/16/2023
Referred to the Joint Committee on Financial Services
Senate
2/16/2023
House concurred
House of Representatives
4/18/2023
Hearing scheduled for 05/02/2023 from 10:00 AM-01:00 PM in A2 and virtual
Joint Conference
4/28/2023
Hearing rescheduled to 05/02/2023 from 10:00 AM-01:00 PM in Gardner Auditorium
Joint Conference
2/8/2024
Reporting date extended to Friday May 17, 2024, pending concurrence
House of Representatives
3/28/2024
Senate concurred
Senate
5/30/2024
Bill reported favorably by committee and referred to the Joint Committee on Health Care Financing
Senate
6/20/2024
Accompanied H1074
House of Representatives
Status Information
Current Status
Introduced(2/16/2023)
Chamber
Senate
Sponsors
Democrat: 24
Republican: 6
Primary Sponsor
Susan Moran
Democrat
Co-Sponsors (29)
Jack Lewis
Democrat
Michael Moore
Democrat
William Driscoll
Democrat
John Cronin
Democrat
John Velis
Democrat
Jason Lewis
Democrat
Patrick O'Connor
Republican
Joanne Comerford
Democrat
Walter Timilty
Democrat
Thomas Stanley
Democrat
Anne Gobi
Democrat
Michael Brady
Democrat
Carmine Gentile
Democrat
Aaron Saunders
Democrat
Michael Soter
Republican
Vanna Howard
Democrat
Steven Xiarhos
Republican
Bruce Tarr
Republican
Fred Barrows
Republican
Paul Mark
Democrat
Brian Murray
Democrat
Salvatore DiDomenico
Democrat
Ryan Fattman
Republican
John Keenan
Democrat
Brendan Crighton
Democrat
Joan Lovely
Democrat
Danillo Sena
Democrat
Jacob Oliveira
Democrat
Liz Miranda
Democrat